Business & Finance

Miracor Diagnostics reports increased net revenue in 2003

Published in Health Business Week, April 30th, 2004

Miracor Diagnostics, Inc., (MRDG) reported that net revenue was $19,199,560 for the year ended December 31, 2003, a 59% increase compared to net revenue of $12,040,908 in 2002.

Net loss was $1,724,227 ($0.11 per share) in 2003 compared to net income of $278,541 ($0.02 per share) for the year 2002.

"The 2003 results reflected the longer than expected turnaround of the six centers we acquired and started-up," stated M. Lee Hulsebus, Miracor's CEO. "For 2004 we will continue to concentrate on revenue growth and capital needs; however, our main focus will be on returning Miracor to profitability."

Miracor opened its 15th diagnostic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-04-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry